Compounds > 1,4-dihydropyridine
Page last updated: 2024-08-26

1,4-dihydropyridine and Arteriosclerosis

1,4-dihydropyridine has been researched along with Arteriosclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mason, RP1
Chobanian, AV1

Reviews

1 review(s) available for 1,4-dihydropyridine and Arteriosclerosis

ArticleYear
Atheroprotective effects of long-acting dihydropyridine-type calcium channel blockers: evidence from clinical trials and basic scientific research.
    Cerebrovascular diseases (Basel, Switzerland), 2003, Volume: 16 Suppl 3

    Topics: Arteriosclerosis; Calcium Channel Blockers; Delayed-Action Preparations; Dihydropyridines; Humans; In Vitro Techniques; Models, Cardiovascular; Randomized Controlled Trials as Topic; Time Factors

2003

Other Studies

1 other study(ies) available for 1,4-dihydropyridine and Arteriosclerosis

ArticleYear
Calcium channel blockers. Lessons learned from MIDAS and other clinical trials.
    JAMA, 1996, Sep-11, Volume: 276, Issue:10

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Calcium Channel Blockers; Cardiovascular Diseases; Clinical Trials as Topic; Confounding Factors, Epidemiologic; Dihydropyridines; Humans; Hypertension

1996